| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Tessier-Lavigne Marc is a Director at Denali Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 40 sells.
Estimated insider holdings value: $45.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 23, 2022 | DNLI Denali Therapeutics Inc. | Director | Sell | 20,000 | $30.48 | $609,600.00 | -1.1% | -5.5% | -39.5% | |
| Nov 2, 2022 | DNLI Denali Therapeutics Inc. | Director | Sell | 20,000 | $30.27 | $605,462.76 | -0.5% | -1.5% | -36.3% | |
| Oct 3, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 10,838 | $702.24 | $7,610,844.04 | -19.0% | -2.0% | +10.0% | |
| Sep 28, 2022 | DNLI Denali Therapeutics Inc. | Director | Sell | 20,000 | $30.82 | $616,303.82 | -0.5% | -16.9% | -34.7% | |
| Aug 23, 2022 | DNLI Denali Therapeutics Inc. | Director | Sell | 20,000 | $31.61 | $632,282.00 | -0.5% | -8.3% | -28.9% | |
| Jul 25, 2022 | DNLI Denali Therapeutics Inc. | Director | Sell | 20,000 | $35.61 | $712,110.00 | -0.5% | -21.4% | -19.8% | |
| Mar 23, 2022 | DNLI Denali Therapeutics Inc. | Director | Sell | 20,000 | $33.83 | $676,582.52 | -0.5% | -20.0% | -31.5% | |
| Mar 21, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 7,439 | $690.00 | $5,132,910.00 | -76.6% | -15.2% | +9.6% | |
| Mar 17, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 12,191 | $678.21 | $8,268,075.00 | -72.9% | -18.1% | +9.1% | |
| Dec 30, 2021 | DNLI Denali Therapeutics Inc. | Director | Sell | 63,131 | $44.43 | $2,805,196.53 | -5.8% | -28.1% | -38.3% |